Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
T2 Biosystems (TTOO)
NASDAQ:TTOO
T2 Biosystems (TTOO) Stock Price & Analysis
1,901 Followers
TTOO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.05 - $29.27
Previous Close$1.67
Volume87.25K
Average Volume (3M)159.61K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$20.37M
Total Debt (Recent Filing)$59.05M
Price to Earnings (P/E)-0.1
Beta-0.85
Next EarningsMar 01, 2023
EPS Estimate-$2.33
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$1.50
EPS (TTM)-16.56
Shares Outstanding7,319,105
R-Squared0.00110
Standard Deviation0.32
10 Day Avg. Volume133,347
30 Day Avg. Volume159,613
Price to Book (P/B)-0.41
Price to Sales (P/S)0.79
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside-3.23% Downside
Rating ConsensusHold
Alpha-0.03
Number of Analyst Covering3
T2 Biosystems News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TTOO FAQ
What was T2 Biosystems’s price range in the past 12 months?
T2 Biosystems lowest stock price was $1.05 and its highest was $29.27 in the past 12 months.
What is T2 Biosystems’s market cap?
Currently, no data Available
When is T2 Biosystems’s upcoming earnings report date?
T2 Biosystems’s upcoming earnings report date is Mar 01, 2023 which is in 30 days.
How were T2 Biosystems’s earnings last quarter?
T2 Biosystems released its earnings results on Nov 10, 2022. The company reported -$2.95 earnings per share for the quarter, missing the consensus estimate of -$2.113 by -$0.837.
Is T2 Biosystems overvalued?
According to Wall Street analysts T2 Biosystems’s price is currently Overvalued.
Does T2 Biosystems pay dividends?
T2 Biosystems does not currently pay dividends.
What is T2 Biosystems’s EPS estimate?
T2 Biosystems’s EPS estimate is -$2.33.
How many shares outstanding does T2 Biosystems have?
T2 Biosystems has 7,319,105 shares outstanding.
What happened to T2 Biosystems’s price movement after its last earnings report?
T2 Biosystems reported an EPS of -$2.95 in its last earnings report, missing expectations of -$2.113. Following the earnings report the stock price went up 2.703%.
Which hedge fund is a major shareholder of T2 Biosystems?
Among the largest hedge funds holding T2 Biosystems’s share is Hussman Strategic Advisors Inc. It holds T2 Biosystems’s shares valued at N/A.
---
T2 Biosystems Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.50
$1.50
Blogger Sentiment
Bearish
TTOO Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 7.2%
Last 30 Days ▼ 7.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.33%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-37.24%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
T2 Biosystems
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
---
Biocept
―
GlobeStar Therapeutics
―
Aileron Therapeutics
―
Cyclo Therapeutics
―
Organovo Holdings
―
---